SE9501285L - Förfarande för framställning av biologiskt aktiva proteiner - Google Patents
Förfarande för framställning av biologiskt aktiva proteinerInfo
- Publication number
- SE9501285L SE9501285L SE9501285A SE9501285A SE9501285L SE 9501285 L SE9501285 L SE 9501285L SE 9501285 A SE9501285 A SE 9501285A SE 9501285 A SE9501285 A SE 9501285A SE 9501285 L SE9501285 L SE 9501285L
- Authority
- SE
- Sweden
- Prior art keywords
- biologically active
- active proteins
- producing biologically
- producing
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501285A SE9501285L (sv) | 1995-04-06 | 1995-04-06 | Förfarande för framställning av biologiskt aktiva proteiner |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501285A SE9501285L (sv) | 1995-04-06 | 1995-04-06 | Förfarande för framställning av biologiskt aktiva proteiner |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9501285D0 SE9501285D0 (sv) | 1995-04-06 |
SE9501285L true SE9501285L (sv) | 1996-10-07 |
Family
ID=20397877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9501285A SE9501285L (sv) | 1995-04-06 | 1995-04-06 | Förfarande för framställning av biologiskt aktiva proteiner |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE9501285L (sv) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716240B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US8791066B2 (en) | 2004-07-13 | 2014-07-29 | Novo Nordisk A/S | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] |
US8841439B2 (en) | 2005-11-03 | 2014-09-23 | Novo Nordisk A/S | Nucleotide sugar purification using membranes |
US8853161B2 (en) | 2003-04-09 | 2014-10-07 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
US8911967B2 (en) | 2005-08-19 | 2014-12-16 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US8916360B2 (en) | 2003-11-24 | 2014-12-23 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US9200049B2 (en) | 2004-10-29 | 2015-12-01 | Novo Nordisk A/S | Remodeling and glycopegylation of fibroblast growth factor (FGF) |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
ES2449195T3 (es) | 2005-01-10 | 2014-03-18 | Ratiopharm Gmbh | Factor estimulante de colonias de granulocitos glicopegilado |
WO2008124406A2 (en) | 2007-04-03 | 2008-10-16 | Neose Technologies, Inc. | Methods of treatment using glycopegylated g-csf |
-
1995
- 1995-04-06 SE SE9501285A patent/SE9501285L/sv not_active Application Discontinuation
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716240B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US8853161B2 (en) | 2003-04-09 | 2014-10-07 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US8916360B2 (en) | 2003-11-24 | 2014-12-23 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US8791066B2 (en) | 2004-07-13 | 2014-07-29 | Novo Nordisk A/S | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] |
US10874714B2 (en) | 2004-10-29 | 2020-12-29 | 89Bio Ltd. | Method of treating fibroblast growth factor 21 (FGF-21) deficiency |
US9200049B2 (en) | 2004-10-29 | 2015-12-01 | Novo Nordisk A/S | Remodeling and glycopegylation of fibroblast growth factor (FGF) |
US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US8911967B2 (en) | 2005-08-19 | 2014-12-16 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US8841439B2 (en) | 2005-11-03 | 2014-09-23 | Novo Nordisk A/S | Nucleotide sugar purification using membranes |
US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
Also Published As
Publication number | Publication date |
---|---|
SE9501285D0 (sv) | 1995-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631903D1 (de) | Diskreter gegenstromchromatographieprozess | |
FI973543A0 (sv) | Förfarande för framställning av heteromultimeriska polypeptider | |
NO982991L (no) | Veksthormon-sekretagoguer | |
FI960278A (sv) | Förfarande för framställning av anatastitandioxid | |
DE69620107T2 (de) | Kristallisationsverfahren | |
SE9501285L (sv) | Förfarande för framställning av biologiskt aktiva proteiner | |
NO974169D0 (no) | Fremgangsmåte for tetra-azacykloalkan-fremstilling | |
EP0816510A4 (en) | PROCESS FOR PRODUCING BIOLOGICALLY ACTIVE FUSED PROTEINS | |
FI961378A (sv) | Förfarande för framställning av N-metyl-3-(1-metyl-4-piperidinyl)-14-indol-5-etansulfonamid | |
FI964229A (sv) | Förfarande för framställning av doxorubicin | |
EE03440B1 (et) | Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess | |
DE69735180D1 (de) | Software-Aktualisierungsverfahren | |
FI973105A0 (sv) | Förfarande för framställning av (4,10-diacetoxi-2alfa-bensoyloxi-5beta,20epoxi-1,7beta-dihydroxi-9-oxotax-11-en-13alfa-yl)-(2R,3S)-3-bensoylamino-3-fenyl-2-hydroxipropionaattrihydrat | |
FI956153A (sv) | Förfarande för framställning av vitlut | |
KR970006251A (ko) | 고단백 유기질 비료의 제조방법 | |
FI974002A0 (sv) | Förfarande för framställning av form 1 ranitidinhydroklorid | |
ITRM960874A0 (it) | Procedimento migliorato per la produzione di 5-idrossimetiltiazolo | |
FI97725B (sv) | Förfarande för framställning av diltiazem | |
FI973341A (sv) | Förfarande för framställning av organosilaner | |
FI943660A (sv) | Framställningsförfarande för 3-karbonylandrostadien-17-karboxamider | |
FR2768308B1 (fr) | Procede de fabrication d'un gel proteique | |
FI950751A0 (sv) | Förfarande för framställning av olefiner | |
FI97745B (sv) | Stödorgan och förfarande för tillverkning av stödorganet | |
FI951441A0 (sv) | Förfarande för framställning av 5-formylamino-pyrimidiner | |
SE9501550D0 (sv) | Förfarande för framställning av transportenhet jämte transportenhet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |